References
- Levin H. S., Benton A. L., Grossman R. G. Neurobehavioural Consequences of Closed Head Injury. Oxford University Press, New York 1982
- Giurgea C., Salama M. Nootropic drugs. Progress in Neuro-Psychopharmacology 1977; 1: 235–247
- Giurgea C., Greinde M. G., Pheat S. Nootropic drugs and ageing. Acta Psychiatrica Belgica 1983; 83: 349–358
- Pugsley T. A., Poschel B. P., Dawns D. A., et al. Some pharmacological and neurochemical properties of a new cognition activator agent, pramiracetam (cl-879). Psychopharmacology Bulletin 1983; 19: 721–726
- Peters B. H., Levin H. S. Memory enhancement after physostigmine treatment in the amnestic syndrome. Archives of Neurology 1977; 34: 215–219
- Levin H. S., Peters B. H., Kalisky Z., et al. Effects of oral physosigmine and lecithin on memory and attention in closed head-injured patients. Central Nervous System Trauma 1986; 3: 333–342
- McLean A., Jr, Stanton K. M., Cardenas D. D., et al. Memory training combined with the use of oral physotigmine. Brain Injury 1987; 2: 145–159